Helicobacter Pylori Non-Invasive Testing Market

Helicobacter Pylori Non-Invasive Testing Market Study by Serology Tests, Stool Antigen Tests, and Urea Breath Tests from 2023 to 2033

Analysis of Helicobacter Pylori Non-Invasive Testing Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Table of Content

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Acronyms Used

3. Research Methodology

4. Executive Summary

5. Market Overview

    5.1. Test Type Overview

    5.2. Market Dynamics

        5.2.1. Drivers

        5.2.2. Restraints

        5.2.3. Opportunities

    5.3. Global Market Value (US$ Mn) Forecast, 2023-2033

    5.4. Global Market Outlook

    5.5. Key Industry Developments

    5.6. Epidemiological Assessment of Helicobacter Pylori

    5.7. New Non-invasive Test launches, by Market Players

    5.8. Key Technological Advancements in Diagnostic Testing

6. Global Market Analysis, by Test Type

    6.1. Introduction

    6.2. Key Findings

    6.3. Global Market Value Share Analysis, by Test Type

    6.4. Global Market Value Forecast, by Test Type, 2023-2033

        6.4.1. Serology Test

        6.4.2. Stool Antigen Test (SAT)

        6.4.3. Urea Breath Test (UBT)

        6.4.4. Endoscopy Test Types

    6.5. Global Market Attractiveness, by Test Type, 2023-2033

7. Global Market Analysis, by Test Method

    7.1. Introduction

    7.2. Key Findings

    7.3. Market Value Share Analysis, by Test Method

    7.4. Market Value Forecast, by Test Method, 2023-2033

        7.4.1. Laboratory-based Tests

        7.4.2. Point-of-Care Tests

    7.5. Market Attractiveness, by Test Method

8. Global Market Analysis, by End-user

    8.1. Introduction

    8.2. Key Findings

    8.3. Market Value Share Analysis, by End-user

    8.4. Market Value Forecast, by End-user, 2023-2033

        8.4.1. Hospitals

        8.4.2. Clinics

        8.4.3. Diagnostic Laboratories

    8.5. Market Attractiveness, by End-user

9. Global Market Analysis and Forecasts, by Region

    9.1. Introduction

    9.2. Regional Outlook

    9.3. Global Market Value Forecast, by Region, 2023-2033

        9.3.1. North America

        9.3.2. Europe

        9.3.3. Asia Pacific

        9.3.4. Latin America

        9.3.5. Middle East & Africa

    9.4. Global Market Attractiveness Analysis, by Region

10. North America Market Analysis

    10.1. Key Findings

    10.2. North America Market Value Forecast, by Country, 2023-2033

        10.2.1. U.S.

        10.2.2. Canada

    10.3. North America Market Value Forecast, by Test Type, 2023-2033

        10.3.1. Serology Test

        10.3.2. Stool Antigen Test (SAT)

        10.3.3. Urea Breath Test (UBT)

    10.4. North America Market Value Forecast, by Test Method, 2023-2033

        10.4.1. Laboratory-based Tests

        10.4.2. Point-of-Care Tests

    10.5. North America Market Value Forecast, by End-user, 2023-2033

        10.5.1. Hospitals

        10.5.2. Clinics

        10.5.3. Diagnostic Laboratories

    10.6. North America Market Attractiveness Analysis

        10.6.1. By Country

        10.6.2. By Test Type

        10.6.3. By Test Method

        10.6.4. By End-user

11. Europe Market Analysis

    11.1. Key Findings

    11.2. Europe Market Value Forecast by Country/Sub-region, 2023-2033

        11.2.1. Germany

        11.2.2. U.K.

        11.2.3. France

        11.2.4. Italy

        11.2.5. Spain

        11.2.6. Rest of Europe

    11.3. Europe Market Value Forecast, by Test Type, 2023-2033

        11.3.1. Serology Test

        11.3.2. Stool Antigen Test (SAT)

        11.3.3. Urea Breath Test (UBT)

        11.3.4. Endoscopy Test Types

    11.4. Europe Market Value Forecast, by Test Method, 2023-2033

        11.4.1. Laboratory-based Tests

        11.4.2. Point-of-Care Tests

    11.5. Europe Market Value Forecast, by End-user, 2023-2033

        11.5.1. Hospitals

        11.5.2. Clinics

        11.5.3. Diagnostic Laboratories

    11.6. Europe Market Attractiveness Analysis

        11.6.1. By Country/Sub-region

        11.6.2. By Test Type

        11.6.3. By Test Method

        11.6.4. By End-user

12. Asia Pacific Market Analysis

    12.1. Key Findings

    12.2. Asia Pacific Market Value Forecast by Country/Sub-region, 2023-2033

        12.2.1. China

        12.2.2. India

        12.2.3. Japan

        12.2.4. Australia

        12.2.5. Rest of Asia Pacific

    12.3. Asia Pacific Market Value Forecast, by Test Type, 2023-2033

        12.3.1. Serology Test

        12.3.2. Stool Antigen Test (SAT)

        12.3.3. Urea Breath Test (UBT)

        12.3.4. Endoscopy Test Types

    12.4. Asia Pacific Market Value Forecast, by Test Method, 2023-2033

        12.4.1. Laboratory-based Tests

        12.4.2. Point-of-Care Tests

    12.5. Asia Pacific Market Value Forecast, by End-user, 2023-2033

        12.5.1. Hospitals

        12.5.2. Clinics

        12.5.3. Diagnostic Laboratories

    12.6. Asia Pacific Market Attractiveness Analysis

        12.6.1. By Country/Sub-region

        12.6.2. By Test Type

        12.6.3. By Test Method

        12.6.4. By End-user

13. Latin America Market Analysis

    13.1. Key Findings

    13.2. Latin America Market Value Forecast by Country/Sub-region, 2023-2033

        13.2.1. Brazil

        13.2.2. Mexico

        13.2.3. Rest of Latin America

    13.3. Latin America Market Value Forecast, by Test Type, 2023-2033

        13.3.1. Serology Test

        13.3.2. Stool Antigen Test (SAT)

        13.3.3. Urea Breath Test (UBT)

        13.3.4. Endoscopy Test Types

    13.4. Latin America Market Value Forecast, by Test Method, 2023-2033

        13.4.1. Laboratory-based Tests

        13.4.2. Point-of-Care Tests

    13.5. Latin America Market Value Forecast, by End-user, 2023-2033

        13.5.1. Hospitals

        13.5.2. Clinics

        13.5.3. Diagnostic Laboratories

    13.6. Latin America Market Attractiveness Analysis

        13.6.1. By Country/Sub-region

        13.6.2. By Test Type

        13.6.3. By Test Method

        13.6.4. By End-user

14. Middle East & Africa Market Analysis

    14.1. Key Findings

    14.2. Middle East & Africa Market Value Forecast by Country/Sub-region, 2023-2033

        14.2.1. GCC Countries

        14.2.2. Israel

        14.2.3. South Africa

        14.2.4. Rest of Middle East & Africa

    14.3. Middle East & Africa Market Value Forecast, by Test Type, 2023-2033

        14.3.1. Serology Test

        14.3.2. Stool Antigen Test (SAT)

        14.3.3. Urea Breath Test (UBT)

        14.3.4. Endoscopy Test Types

    14.4. Middle East & Africa Market Value Forecast, by Test Method, 2023-2033

        14.4.1. Laboratory-based Tests

        14.4.2. Point-of-Care Tests

    14.5. Middle East & Africa Market Value Forecast, by End-user, 2023-2033

        14.5.1. Hospitals

        14.5.2. Clinics

        14.5.3. Diagnostic Laboratories

    14.6. Middle East & Africa Market Attractiveness Analysis

        14.6.1. By Country/Sub-region

        14.6.2. By Test Type

        14.6.3. By Test Method

        14.6.4. By End-user

15. Competitive Landscape

    15.1. Competition Matrix

    15.2. Market Share Analysis, by Company, 2018

    15.3. Company Profiles

        15.3.1. DiaSorin S.p.A.

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Financial Overview

            15.3.1.3. Test Type Portfolio

            15.3.1.4. SWOT Analysis

            15.3.1.5. Strategic Overview

        15.3.2. Meridian Bioscience, Inc.

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Financial Overview

            15.3.2.3. Test Type Portfolio

            15.3.2.4. SWOT Analysis

            15.3.2.5. Strategic Overview

        15.3.3. Exalenz Bioscience Ltd.

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Financial Overview

            15.3.3.3. Test Type Portfolio

            15.3.3.4. SWOT Analysis

            15.3.3.5. Strategic Overview

        15.3.4. Alere

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Financial Overview

            15.3.4.3. Test Type Portfolio

            15.3.4.4. SWOT Analysis

            15.3.4.5. Strategic Overview

        15.3.5. Thermo Fisher Scientific

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Financial Overview

            15.3.5.3. Test Type Portfolio

            15.3.5.4. SWOT Analysis

            15.3.5.5. Strategic Overview

        15.3.6. Biomerica, Inc.

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Financial Overview

            15.3.6.3. Test Type Portfolio

            15.3.6.4. SWOT Analysis

            15.3.6.5. Strategic Overview

        15.3.7. Certest Biotec S.L.

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Financial Overview

            15.3.7.3. Test Type Portfolio

            15.3.7.4. SWOT Analysis

            15.3.7.5. Strategic Overview

        15.3.8. Sekisui Diagnostics

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Financial Overview

            15.3.8.3. Test Type Portfolio

            15.3.8.4. SWOT Analysis

            15.3.8.5. Strategic Overview

        15.3.9. CorisBioconcept SPRL

            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.9.2. Financial Overview

            15.3.9.3. Test Type Portfolio

            15.3.9.4. SWOT Analysis

            15.3.9.5. Strategic Overview

        15.3.10. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.

            15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.10.2. Financial Overview

            15.3.10.3. Test Type Portfolio

            15.3.10.4. SWOT Analysis

            15.3.10.5. Strategic Overview

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 01: Global Market Value (US$ Mn) Forecast, by Non-invasive Test Type, 2023–2033

Table 02: Global Market Value (US$ Mn) Forecast, by Test Method, 2023–2033

Table 03: Global Market Value (US$ Mn) Forecast, by End User, 2023–2033

Table 04: Global Market Value (US$ Mn) Forecast, by Region, 2023–2033

Table 05: North America Market Revenue (US$ Mn) Forecast, by Country, 2023–2033

Table 06: North America Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2023–2033

Table 07: North America Market Revenue (US$ Mn) Forecast, by Test Method, 2023–2033

Table 08: North America Market Revenue (US$ Mn) Forecast, by End User, 2023–2033

Table 09: Europe Market Revenue (US$ Mn) Forecast, by Country, 2023–2033

Table 10: Europe Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2023–2033

Table 11: Europe Market Revenue (US$ Mn) Forecast, by Test Method, 2023–2033

Table 12: Europe Market Revenue (US$ Mn) Forecast, by End User, 2023–2033

Table 13: Asia Pacific Market Revenue (US$ Mn) Forecast, by Country, 2023–2033

Table 14: Asia Pacific Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2023–2033

Table 15: Asia Pacific Market Revenue (US$ Mn) Forecast, by Test Method, 2023–2033

Table 16: Asia Pacific Market Revenue (US$ Mn) Forecast, by End User, 2023–2033

Table 17: Latin America Market Revenue (US$ Mn) Forecast, by Country, 2023–2033

Table 18: Latin America Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2023–2033

Table 19: Latin America Market Revenue (US$ Mn) Forecast, by Test Method, 2023–2033

Table 20: Latin America Market Revenue (US$ Mn) Forecast, by End User, 2023–2033

Table 21: Middle East & Africa Market Revenue (US$ Mn) Forecast, by Country, 2023–2033

Table 22: Middle East & Africa Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2023–2033

Table 23: Middle East & Africa Market Revenue (US$ Mn) Forecast, by Test Method, 2023–2033

Table 24: Middle East & Africa Market Revenue (US$ Mn) Forecast, by End User, 2023–2033

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 01: Prevalence of Helicobacter Pylori, North America, 2022

Figure 02: Prevalence of Helicobacter Pylori, Europe, 2022

Figure 03: Prevalence of Helicobacter Pylori, Asia Pacific, 2022

Figure 04: Prevalence of Helicobacter Pylori, Latin America, 2022

Figure 05: Prevalence of Helicobacter Pylori, Middle East & Africa, 2022

Figure 06: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, 2023–2033

Figure 07: Opportunity Map, by Non-invasive Test Type and Test Method, 2022

Figure 08: Opportunity Map, by End User, 2022

Figure 09: Global Market Value Share, by Region (2022)

Figure 10: Global Market Value Share, by Test Method (2022)

Figure 11: Global Market Value Share, by Non-Invasive Test Type (2022)

Figure 12: Global Market Value Share, by End-user (2022)

Figure 13: Global Market Value Share, by Non-invasive Test Type, 2020 and 2026

Figure 14: Global Market Revenue (US$ Mn), by Serology Test, 2023–2033

Figure 15: Global Market Revenue (US$ Mn), by SAT, 2023–2033

Figure 16: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by UBT, 2023–2033

Figure 17: Global Market Attractiveness, by Non-invasive Test Type, 2023–2033

Figure 18: Global Market Value Share, by Test Method, 2020 and 2026

Figure 19: Global Market Attractiveness, by Test Method, 2023–2033

Figure 20: Global Market Revenue (US$ Mn), by Laboratory Based Tests, 2023–2033

Figure 21: Global Market Revenue (US$ Mn), by Point-of-Care Tests, 2023–2033

Figure 22: Global Market Value Share, by End User, 2020 and 2026

Figure 23: Global Market Attractiveness, by End User, 2023–2033

Figure 24: Global Market Revenue (US$ Mn), by Hospitals, 2023–2033

Figure 25: Global Market Revenue (US$ Mn), by Clinics, 2023–2033

Figure 26: Global Market Revenue (US$ Mn), by Diagnostic Labs, 2023–2033

Figure 27: Global Market Value Share (%), by Region, 2020 and 2026

Figure 28: Global Market Attractiveness, by Region, 2023–2033

Figure 29: North America Market Value Share, by Country, 2020 and 2026

Figure 30: North America Market Attractiveness, by Country, 2023–2033

Figure 31: North America Market Value Share, by Non-invasive Test Type, 2020 and 2026

Figure 32: North America Market Attractiveness, by Non-invasive Test Type, 2023–2033

Figure 33: North America Market Value Share, by Test Method, 2020 and 2026

Figure 34: North America Market Attractiveness, by Test Method, 2023–2033

Figure 35: North America Market Value Share, by End User, 2020 and 2026

Figure 36: North America Market Attractiveness, by End User, 2023–2033

Figure 37: Europe Market Value Share, by Country, 2020 and 2026

Figure 38: Europe Market Attractiveness, by Country, 2023–2033

Figure 39: Europe Market Value Share, by Non-invasive Test Type, 2020 and 2026

Figure 40: Europe Market Attractiveness, by Non-invasive Test Type, 2023–2033

Figure 41: Europe Market Value Share, by Test Method, 2020 and 2026

Figure 42: Europe Market Attractiveness, by Test Method, 2023–2033

Figure 43: Europe Market Value Share, by End User, 2020 and 2026

Figure 44: Europe Market Attractiveness, by End User, 2023–2033

Figure 45: Asia Pacific Market Value Share, by Country, 2020 and 2026

Figure 46: Asia Pacific Market Attractiveness, by Country, 2023–2033

Figure 47: Asia Pacific Market Value Share, by Non-invasive Test Type, 2020 and 2026

Figure 48: Asia Pacific Market Attractiveness, by Non-invasive Test Type, 2023–2033

Figure 49: Asia Pacific Market Value Share, by Test Method, 2020 and 2026

Figure 50: Asia Pacific Market Attractiveness, by Test Method, 2023–2033

Figure 51: Asia Pacific Market Value Share, by End User, 2020 and 2026

Figure 52: Asia Pacific Market Attractiveness, by End User, 2023–2033

Figure 53: Latin America Market Value Share, by Country, 2020 and 2026

Figure 54: Latin America Market Attractiveness, by Country, 2023–2033

Figure 55: Latin America Market Value Share, by Non-invasive Test Type, 2020 and 2026

Figure 56: Latin America Market Attractiveness, by Non-invasive Test Type, 2023–2033

Figure 57: Latin America Market Value Share, by Test Method, 2020 and 2026

Figure 58: Latin America Market Attractiveness, by Test Method, 2023–2033

Figure 59: Latin America Market Value Share, by End User, 2020 and 2026

Figure 60: Latin America Market Attractiveness, by End User, 2023–2033

Figure 61: Middle East & Africa Market Value Share, by Country, 2020 and 2026

Figure 62: Middle East & Africa Market Attractiveness, by Country, 2023–2033

Figure 63: Middle East & Africa Market Value Share, by Non-invasive Test Type, 2020 and 2026

Figure 64: Middle East & Africa Market Attractiveness, by Non-invasive Test Type, 2023–2033

Figure 65: Middle East & Africa Market Value Share, by Test Method, 2020 and 2026

Figure 66: Middle East & Africa Market Attractiveness, by Test Method, 2023–2033

Figure 67: Middle East & Africa Market Value Share, by End User, 2020 and 2026

Figure 68: Middle East & Africa Market Attractiveness, by End User, 2023–2033

Figure 69: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing, Company Share Analysis, 2022 (Estimated)

Figure 70: DiaSorin S.p.A Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022

Figure 71: DiaSorin S.p.A Breakdown of Net Sales (%), by Region, 2022

Figure 72: Meridian Bioscience, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022

Figure 73: Meridian Bioscience, Inc. Breakdown of Net Sales (%), by Business Segment, 2022

Figure 74: Exalenz Bioscience Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022

Figure 75: Exalenz Bioscience Ltd. R&D Expenditure (US$ Mn), 2018-2022

Figure 76: Alere (Abbott) Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022

Figure 77: Alere (Abbott) Breakdown of Net Sales (%), by Business Segment, 2022

Figure 78: Thermo Fisher Scientific Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022

Figure 79: Thermo Fisher Scientific Breakdown of Net Sales (%), by Business Segment, 2022

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Helicobacter Pylori Non-Invasive Testing Market

Schedule a Call